Press Release: BigBear.ai Announces Fourth Quarter 2025 Results; Releases 2026 Financial Outlook

Dow Jones
03/03
   --  Closed 2025 with strongest financial position in Company history 
 
   --  Total cash and investments of $462 million as of December 31, 2025 
 
   --  Settled the remaining $125 million of 2029 Convertible notes, primarily 
      through the Company's exercise of debt-to-equity conversion features in 
      January 2026. 
 
   --  Closed acquisitions of Ask Sage (December 2025), and CargoSeer (January 
      2026), and expanded into the Middle East, which positions the Company for 
      solid growth in 2026 
 
   --  The Company projects full-year 2026 revenue between $135 million and 
      $165 million, representing approximately 17% growth at the midpoint 
      compared to full-year 2025 revenue of $128 million 
MCLEAN, Va.--(BUSINESS WIRE)--March 02, 2026-- 

BigBear.ai Holdings, Inc. (NYSE: BBAI) ("BigBear.ai" or the "Company"), a leader in AI-powered decision intelligence solutions, today announced financial results for the fourth quarter of 2025 and issued an investor presentation that has been posted to the Investor Relations section of the Company's website.

"At the start of 2025, we set out to transform our financial foundations to establish a base from which to accelerate in 2026. We have delivered exactly that. As of year-end 2025, BigBear.ai is in the strongest financial position in the company's history. I am tremendously grateful to our team for the work they have done. We have reduced our debt by more than 90%, established a powerful cash position that gives us the freedom to invest in catalytic technologies, expanded internationally, and acquired two highly specialized technology companies which play directly into our two core markets in national security and travel & trade," said Kevin McAleenan, CEO of BigBear.ai.

"The U.S. Government's AI Acceleration Strategy plays directly to our strengths. Unlike many AI and technology companies, we deeply understand the reality operators face. Our national security customers and global partners need the ability to apply emerging tech securely, more rapidly and with greater flexibility than ever before to address emerging threats and challenges. And that's what we intend to keep doing for them."

"There were many significant milestones in 2025: we raised $693 million of proceeds from our ATM facilities and warrants; and closed the purchase of Ask Sage, the largest acquisition in BigBear's history. Further, we have already started 2026 by settling our 2029 Notes, which amounted to $182 million in the beginning of 2025, and also closing on the acquisition of CargoSeer," said Sean Ricker, CFO of BigBear.ai.

Financial Highlights

   --  Revenue decreased 38% to $27.3 million for the fourth quarter of 2025, 
      compared to $43.8 million for the fourth quarter of 2024 primarily due to 
      lower volume on Army programs. 
 
   --  Gross margin was 20.3% in the fourth quarter of 2025, compared to 37.4% 
      in the fourth quarter of 2024, due to significant one-time high margin 
      contracts in the fourth quarter of 2024, which did not recur in the 
      fourth quarter of 2025. 
 
   --  Net loss in the fourth quarter of 2025 was $5.8 million, compared to a 
      net loss of $138.2 million for the fourth quarter of 2024. The decrease 
      in net loss was primarily driven by non-cash gain of $50.2 million 
      related to derivative liabilities associated with changes in the fair 
      value of the convertible features of the 2029 and 2026 Notes and warrants 
      for the fourth quarter of 2025 compared to a non-cash loss of $93.3 
      million for the fourth quarter of 2024. Further there was a non-cash loss 
      on extinguishment of debt in fourth quarter of 2024 of $31.3 million. 
      Additionally, the Company realized an income tax benefit of $21.7 million 
      related to a change in tax valuation allowances resulting from the Ask 
      Sage acquisition. This was partially offset by impairment of long-lived 
      assets of $53.4 million during the fourth quarter of 2025. 
 
   --  Non-GAAP Adjusted EBITDA* of $(10.3) million for the fourth quarter of 
      2025 compared to $2.0 million for the fourth quarter of 2024, primarily 
      driven by a decrease in gross margin as well as an increase in research 
      and development, and SG&A expenses. 

The above information on financial outlook, and other sections of this release contain forward-looking statements, which are based on the Company's current expectations. Actual results may differ materially from those projected. It is the Company's practice not to incorporate adjustments into its financial outlook for proposed acquisitions, divestitures, changes in law, or new accounting standards until such items have been consummated, enacted, or adopted, as the case may be. For additional factors that may impact the Company's actual results, refer to the "Forward-Looking Statements" section in this release.

 
*EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are non-GAAP financial 
measures. See the "Non-GAAP Financial Measures" section in this press release 
for additional information and reconciliations. 
 
 
 
 
 
         Summary of Results for the Fourth Quarter Ended and Years Ended 
                     December 31, 2025 and December 31, 2024 
                                   (Unaudited) 
 
                          Three Months Ended                Years Ended 
                             December 31,                   December 31, 
                     ----------------------------  ------------------------------ 
$ thousands (expect 
per share amounts)       2025           2024           2025           2024 
-------------------   -----------    -----------    -----------    ----------- 
Revenues             $     27,300   $     43,827   $    127,672   $    158,236 
Cost of revenues           21,752         27,422         99,194        113,016 
-------------------   -----------    -----------    -----------    ----------- 
    Gross margin            5,548         16,405         28,478         45,220 
Operating expenses: 
    Selling, 
     general and 
     administrative        25,658         22,243         95,132         80,040 
    Research and 
     development            4,818          2,334         16,752         10,863 
    Restructuring 
     charges                  113            (30)         4,370          1,287 
    Transaction 
     expenses               2,082             --          2,082          1,450 
    Impairment of 
     long-lived 
     assets                53,403             --         53,403             -- 
    Goodwill 
     impairment                --             --         70,636         85,000 
-------------------   -----------    -----------    -----------    ----------- 
Operating loss            (80,526)        (8,142)      (213,897)      (133,420) 
    Interest 
     expense                3,977          6,258         18,116         25,647 
    Interest income        (6,687)          (486)       (13,253)        (2,293) 
    Net (decrease) 
     increase in 
     fair value of 
     derivatives          (50,168)        93,262         92,794        107,658 
    Loss on 
     extinguishment 
     of debt                   --         31,272          2,577         31,272 
    Other (income) 
     expense                  (40)            11          1,505             99 
-------------------   -----------    -----------    -----------    ----------- 
Loss before taxes         (27,608)      (138,459)      (315,636)      (295,803) 
    Income tax 
     benefit              (21,778)          (278)       (21,722)          (256) 
-------------------   -----------    -----------    -----------    ----------- 
Net loss             $     (5,830)  $   (138,181)  $   (293,914)  $   (295,547) 
-------------------   -----------    -----------    -----------    ----------- 
 
Basic and diluted 
 net loss per 
 share               $      (0.01)  $      (0.55)  $      (0.82)  $      (1.27) 
 
Weighted-average 
shares 
outstanding: 
    Basic             436,683,643    250,575,733    358,801,375    233,604,500 
    Diluted           436,683,643    250,575,733    358,801,375    233,604,500 
-------------------   -----------    -----------    -----------    ----------- 
 
 
 
 
 
 
                    Consolidated Balance Sheets as of 
                  December 31, 2025 and December 31, 2024 
                                (Unaudited) 
 
$ in thousands (except per share           December 31,     December 31, 
amounts)                                       2025             2024 
----------------------------------------  --------------  ---------------- 
Assets 
Current assets: 
    Cash and cash equivalents              $     87,126    $     50,141 
    Restricted cash                               5,521              -- 
    Available for sale investments              200,461              -- 
    Accounts receivable, less allowance 
     for credit losses                           22,703          38,953 
    Contract assets                                 218             895 
    Prepaid expenses and other current 
     assets                                      14,514           3,768 
----------------------------------------      ---------       --------- 
Total current assets                            330,543          93,757 
----------------------------------------      ---------       --------- 
Non-current assets: 
    Property and equipment, net                   1,562           1,566 
    Goodwill                                    241,100         119,081 
    Intangible assets, net                      139,470         119,119 
    Available for sale investments              173,949              -- 
    Right-of-use assets                           7,063           9,263 
    Other non-current assets                        860             990 
----------------------------------------      ---------       --------- 
Total assets                               $    894,547    $    343,776 
----------------------------------------      ---------       --------- 
 
Liabilities and stockholders' equity 
(deficit) 
Current liabilities: 
    Accounts payable                       $      6,088    $      8,455 
    Short-term debt, including current 
     portion of long-term debt                   16,560             818 
    Accrued liabilities                          19,649          19,496 
    Contract liabilities                         14,756           2,541 
    Current portion of long-term lease 
     liability                                    1,095           1,068 
    Derivative liabilities                      116,906         170,515 
    Other current liabilities                    10,466              73 
----------------------------------------      ---------       --------- 
Total current liabilities                       185,520         202,966 
----------------------------------------      ---------       --------- 
Non-current liabilities: 
    Long-term debt, net                          90,484         135,404 
    Long-term lease liability                     6,673           9,120 
----------------------------------------      ---------       --------- 
Total liabilities                               282,677         347,490 
----------------------------------------      ---------       --------- 
Stockholders' equity (deficit) 
    Common stock, par value $0.0001; 
     500,000,000 shares authorized and 
     436,955,655 shares issued and 
     outstanding at December 31, 2025 
     and 251,554,378 shares issued and 
     outstanding at December 31, 2024                46              26 
    Additional paid-in capital                1,534,792         625,130 
    Treasury stock, at cost 9,952,803 
     shares at December 31, 2025 and 
     December 31, 2024                          (57,350)        (57,350) 
    Accumulated deficit                        (865,555)       (571,641) 
    Accumulated other comprehensive 
     (loss) income                                  (63)            121 
----------------------------------------      ---------       --------- 
Total stockholders' equity (deficit)            611,870          (3,714) 
Total liabilities and stockholders' 
 equity (deficit)                          $    894,547    $    343,776 
----------------------------------------      ---------       --------- 
 
 
 
 
 
 
  Consolidated Statements of Cash Flows for the Fourth Quarter and 
   Years Ended December 31, 2025 and December 31, 2024 (Unaudited) 
 
                       Three Months Ended          Years Ended 
                          December 31,             December 31, 
                     ----------------------  ------------------------ 
$ in thousands          2025        2024        2025        2024 
-------------------   --------    --------    --------    -------- 
Cash flows from 
operating 
activities: 
Net loss             $  (5,830)  $(138,181)  $(293,914)  $(295,547) 
Adjustments to 
reconcile net loss 
to net cash used in 
operating 
activities: 
    Depreciation 
     and 
     amortization 
     expense             4,233       3,133      15,281      11,873 
    Amortization of 
     debt discount 
     and issuance 
     costs               2,108       3,169       9,057      13,428 
    Accretion of 
     discount on 
     investments in 
     debt 
     securities           (841)         --        (966)         -- 
    Equity-based 
     compensation 
     expense             6,290       5,053      23,330      21,127 
    Goodwill 
     impairment             --          --      70,636      85,000 
    Impairment of 
     long-lived 
     assets             53,403          --      53,403          -- 
    Non-cash lease 
     expense               246         167       2,200         720 
    Provision for 
     doubtful 
     accounts               --           8         351         228 
    Deferred income 
     tax benefit       (21,660)       (291)    (21,660)       (328) 
    Loss on 
     extinguishment 
     of debt                --      31,272       2,577      31,272 
    (Decrease) 
     increase in 
     fair value of 
     derivatives       (50,168)     93,262      92,794     107,658 
Changes in assets 
and liabilities: 
    Decrease 
     (increase) in 
     accounts 
     receivable          2,998      (6,357)     17,237     (11,753) 
    Decrease in 
     contract 
     assets              1,962         849         677       3,927 
    (Increase) 
     decrease in 
     prepaid 
     expenses and 
     other assets       (7,232)        536     (10,370)      2,076 
    (Decrease) 
     increase in 
     accounts 
     payable            (2,809)      4,197      (5,698)     (4,027) 
    Decrease in 
     accrued 
     expenses           (6,768)    (10,483)       (254)     (2,873) 
    (Decrease) 
     increase in 
     contracts 
     liabilities          (373)         28         593         514 
    Increase 
     (decrease) in 
     other 
     liabilities         2,607      (1,168)      2,775      (1,414) 
-------------------   --------    --------    --------    -------- 
Net cash used in 
 operating 
 activities            (21,834)    (14,806)    (41,951)    (38,119) 
-------------------   --------    --------    --------    -------- 
Cash flows from 
investing 
activities: 
    Purchases of 
     investments in 
     debt 
     securities       (305,706)         --    (564,445)         -- 
    Proceeds from 
     maturities and 
     sales of 
     investments in 
     debt 
     securities        191,154          --     191,154          -- 
    Acquisition of 
     business, net 
     of cash 
     acquired         (229,025)         --    (229,025)     13,935 
    Purchases of 
     property and 
     equipment            (252)       (180)       (525)       (484) 
    Capitalized 
     software 
     development 
     costs                  --      (3,234)     (3,841)    (10,630) 
-------------------   --------    --------    --------    -------- 
Net cash (used in) 
 provided by 
 investing 
 activities           (343,829)     (3,414)   (606,682)      2,821 
-------------------   --------    --------    --------    -------- 
Cash flows from 
financing 
activities: 
    Proceeds from 
     issuance of 
     shares for 
     exercised RDO 
     and PIPE 
     warrants               --          --      64,673      53,809 
    Payment of 
     Private 
     Placement and 
     Registered 
     Direct 
     Offering 
     transaction 
     costs                  --          --        (551)         -- 
    Proceeds from 
    at-the-market 
    offering                --          --     637,073          -- 
    Payment of 
     transaction 
     costs for 
     at-the-market 
     offering               --          --      (8,284)         -- 
    Proceeds from 
     short-term 
     borrowings             --         817          --         817 
    Repayment of 
     short-term 
     borrowings             --          --        (818)     (1,229) 
    Payment of debt 
     issuance costs 
     to third 
     parties                --        (349)     (4,679)       (349) 
    Proceeds from 
     exercise of 
     options                61         302       3,665         421 
    Issuance of 
     common stock 
     upon ESPP 
     purchase            1,310         760       2,379       1,367 
    Payments of tax 
     withholding 
     from the 
     issuance of 
     common stock         (108)        765      (2,145)     (2,378) 
-------------------   --------    --------    --------    -------- 
Net cash provided 
 by financing 
 activities              1,263       2,295     691,313      52,458 
-------------------   --------    --------    --------    -------- 
Effect of foreign 
 currency rate 
 changes on cash, 
 cash equivalents, 
 and restricted 
 cash                      467         482        (174)        424 
Net (decrease) 
 increase in cash, 
 cash equivalents 
 and restricted 
 cash                 (363,933)    (15,443)     42,506      17,584 
Cash, cash 
 equivalents, and 
 restricted cash at 
 the beginning of 
 the period            456,580      65,584      50,141      32,557 
-------------------   --------    --------    --------    -------- 
Cash, cash 
 equivalents, and 
 restricted cash at 
 the end of the 
 period              $  92,647   $  50,141   $  92,647   $  50,141 
-------------------   --------    --------    --------    -------- 
 
 
 
 
 
 
 EBITDA* and Adjusted EBITDA* for the Fourth Quarter and Years Ended 
               December 31, 2025 and December 31, 2024 
                             (Unaudited) 
 
                       Three Months Ended          Years Ended 
                           December 31,            December 31, 
                      ---------------------  ------------------------ 
$ thousands             2025        2024        2025        2024 
--------------------   -------    --------    --------    -------- 
Net loss              $ (5,830)  $(138,181)  $(293,914)  $(295,547) 
Interest expense         3,977       6,258      18,116      25,647 
Interest income         (6,687)       (486)    (13,253)     (2,293) 
Income tax benefit     (21,778)       (278)    (21,722)       (256) 
Depreciation and 
 amortization            4,233       3,132      15,281      11,872 
--------------------   -------    --------    --------    -------- 
EBITDA                 (26,085)   (129,555)   (295,492)   (260,577) 
Adjustments: 
    Equity-based 
     compensation        6,290       5,053      23,330      21,127 
    Employer payroll 
     taxes related 
     to equity-based 
     compensation(1)       125         244       2,011         985 
    Net (decrease) 
     increase in 
     fair value of 
     derivatives(2)    (50,168)     93,262      92,794     107,658 
    Restructuring 
     charges(3)            113         (30)      4,370       1,287 
    Non-recurring 
     strategic 
     initiatives(4)      3,944       1,517       9,075       6,459 
    Non-recurring 
     litigation(5)          --          23          30       1,142 
    Transaction 
     expenses(6)         2,082          --       2,082       1,450 
    Non-recurring 
     integration 
     costs(7)               44         175          44       1,800 
    Goodwill 
     impairment(8)          --          --      70,636      85,000 
    Impairment of 
     long-lived 
     assets(9)          53,403          --      53,403          -- 
    Loss on 
     extinguishment 
     of debt(10)            --      31,272       2,577      31,272 
--------------------   -------    --------    --------    -------- 
Adjusted EBITDA       $(10,252)  $   1,961   $ (35,140)  $  (2,397) 
--------------------   -------    --------    --------    -------- 
 
 
(1)    Includes employer payroll taxes due upon the vesting of equity awards 
       granted to employees. 
(2)    The change in fair value of derivatives during the year ended December 
       31, 2025 relates to the remeasurement of the 2025 warrants, IPO 
       warrants and the 2026 and 2029 Notes Conversion Options derivative 
       liabilities. The change during the year ended December 31, 2025, 
       relates to the $14.0 million loss recorded upon the exercise of the 
       2024 RDO and 2024 PIPE Warrants (the "2024 Warrants") and issuance of 
       the warrants in 2025 (the "2025 Warrants") in connection with the 
       warrant exercise agreements entered into on February 5, 2025. During 
       the year ended December 31, 2025, there was loss related to a 
       mark-to-market adjustment of $59.9M for the debt to equity conversions 
       during the period. There was a gain related to the fair market value 
       adjustment on the 2025 warrants and the private warrants of $2.3 
       million. Additionally, there was a loss of $20.8 million fair market 
       value adjustments of the 2026 and 2029 Notes Conversion Option, during 
       the year ended December 31, 2025. 
       The increase in fair value of derivatives during the year ended 
       December 31, 2024, relates to the $42.3 million loss recorded upon the 
       exercise of the 2023 RDO and 2023 PIPE Warrants (the "2023 Warrants") 
       and issuance of the warrants in 2024 (the "2024 Warrants") in 
       connection with the warrant exercise agreements entered into on 
       February 27, 2024 and March 4, 2024. The additional loss relates to 
       $11.4 million fair market value adjustment of the 2026 Notes Conversion 
       Option, 2024 Warrants, and IPO Private Warrants during the year ended 
       December 31, 2024. This loss is net of a $10.6 million gain related to 
       the issuance of the 2024 Warrants and was further offset by a reduction 
       of $11.4 million upon remeasurement of the 2024 Warrants and IPO 
       Private Warrants' fair value during the year ended December 31, 2024. 
       Additionally, for the year-ended December 31, 2024, there was a $54.4 
       million loss related to the fair market valuation of the derivative 
       liabilities in connection with the 2029 Convertible Notes. 
(3)    Employee separation costs associated with strategic reviews of the 
       Company's capacity and future projections to better align the 
       organization and cost structure and improve the affordability of its 
       products and services. 
(4)    Non-recurring professional fees incurred in connection with discrete, 
       non-recurring strategic initiatives, including business transformation 
       and strategy realignment consulting services which management does not 
       consider part of the Company's ongoing operating expenses. 
(5)    Non-recurring litigation consists primarily of legal settlements and 
       related fees for specific proceedings that we have determined arise 
       outside of the ordinary course of business based on the following 
       considerations which we assess regularly: (1) the frequency of similar 
       cases that have been brought to date, or are expected to be brought 
       within two years; (2) the complexity of the case; (3) the nature of the 
       remedy(ies) sought, including the size of any monetary damages sought; 
       (4) offensive versus defensive posture of us; (5) the counterparty 
       involved; and (6) our overall litigation strategy. 
(6)    Transaction expenses during the year ended December 31, 2024 consist 
       primarily of diligence, legal and other related expenses incurred 
       associated with the Pangiam acquisition. Transaction expenses during 
       the year ended December 31, 2025 consist primarily of diligence, legal 
       and other related expenses incurred associated with the Ask Sage 
       acquisition, as well as expenses incurred to explore other acquisition 
       options. 
(7)    Non-recurring internal integration costs related to the Pangiam and Ask 
       Sage acquisitions, respectively. 
(8)    During the year ended December 31, 2024, the Company recognized a 
       non-cash goodwill impairment charge primarily driven by a decrease in 
       share price during the quarter compared to the share price of the 
       equity issued as consideration for the purchase of Pangiam. During the 
       year ended December 31, 2025, the company recognized a non-cash 
       goodwill impairment charge primarily driven by a change in forecast 
       during the second quarter of 2025. 
(9)    During December 2025, the Company recognized a non-cash impairment of 
       its intangible assets, primarily driven by certain revenue contracts 
       with the U.S. government that resulted in downward revisions of short 
       and long-term forecasts. 
(10)   Loss on extinguishment of debt is related to voluntary conversions of 
       the 2029 Notes to common stock and the related extinguishment of 
       unamortized debt discount and debt costs. 
 
*EBITDA and Adjusted EBITDA are non-GAAP financial measures. See the "Non-GAAP 
Financial Measures" section in this press release for additional information 
and reconciliations. 
 
 
 
 

Forward-Looking Statements

This release contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933 (the "Securities Act"), the Securities Exchange Act of 1934 (the "Exchange Act") and the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "project," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our industry, future events, and other statements that are not historical facts. These statements are based on current expectations and beliefs concerning future developments and their potential effects on us and should not be relied upon as representing BigBear's assessment as of any date subsequent to the date of this release. There can be no assurance that future developments affecting us will be those that we have anticipated. Many actual events and circumstances are beyond our control. These forward-looking statements are subject to a number of risks and uncertainties, including those relating to: changes in domestic and foreign business, market, financial, political, and legal conditions; the uncertainty of projected financial information; delays caused by factors outside of our control, including changes in fiscal or contracting policies or decreases in available government funding, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics; changes in government programs or applicable requirements; budgetary constraints, including any potential constraints as a result of recent or future federal government layoffs, including automatic reductions as a result of "sequestration" or similar measures and constraints imposed by any lapses in appropriations for the federal government or certain of its departments and agencies, including government shutdowns or the ability of the U.S. federal government to unilaterally cancel a contract with or without cause, and more specifically, the potential impact of the U.S. DOGE Service Temporary Organization on government spending and terminating contracts for convenience; the failure of contracts comprising backlog to result in revenue due to changes in funding, terminations for convenience, or option periods going unexercised; the impact of tariffs or other restrictive trade measures; implementation of spending limits or changes in budgetary constraints; influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers; changes in our ability to successfully compete for and receive task orders and generate revenue under Indefinite Delivery/Indefinite Quantity contracts; our ability to realize the benefits of the strategic partnerships; risks that the new businesses will not be integrated successfully or that the combined companies will not realize estimated cost savings; failure to realize anticipated benefits of the combined operations; potential delays or changes in the government appropriations or procurement processes; our ability to remediate a material weakness in our internal control over financial reporting; risks regarding the market and our customers accepting and adopting our products, including future new product offerings; the high degree of uncertainty of the level of demand for, and market utilization of, our solutions and products; our ability to successfully execute and realize the benefits of joint ventures, channel sales relationships, partnerships, strategic alliances, subcontracting opportunities, customer contracts and other commercial agreements to which we are a party; and those factors discussed in the Company's reports and other documents filed with the SEC, including under the heading "Risk Factors." If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from those projected by

(MORE TO FOLLOW) Dow Jones Newswires

March 02, 2026 16:15 ET (21:15 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10